(Q35532455)

English

A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment

scientific article published on May 1998

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

0 references

author name string

Pitt P

1

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Li F

2

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Todd P

3

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Webber D

4

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Pack S

5

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Moniz C

6

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

language of work or name

0 references

publication date

1 May 1998

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

53

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

351-356

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

Vertebral fracture assessment using a semiquantitative technique.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745232

27 July 2018

Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745232

27 July 2018

Osteoporosis in patients with inflammatory bowel disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745232

27 July 2018

Bone histomorphometry in glucocorticoid-induced osteoporosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745232

27 July 2018

Biochemical markers of bone turnover in women with surgically treated carcinoma of the breast.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1745232

26 September 2018

Steroid-induced fractures and bone loss in patients with asthma

1 reference

https://pubmed.ncbi.nlm.nih.gov/9708225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bone mineral in lumbar spine, femoral neck and femoral shaft measured by dual photon absorptiometry with 153-gadolineum in prednisone treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/9708225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD)

1 reference

https://pubmed.ncbi.nlm.nih.gov/9708225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucocorticoid-Induced Osteoporosis: Pathogenesis and Management

1 reference

https://pubmed.ncbi.nlm.nih.gov/9708225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin

1 reference

https://pubmed.ncbi.nlm.nih.gov/9708225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic bone changes accompanying early rheumatoid arthritis in patients treated with nonsteroidal antiinflammatory drugs alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/9708225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Glucocorticoid-induced osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9708225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent cyclic therapy with etidronate in the prevention of corticosteroid induced bone loss

1 reference

https://pubmed.ncbi.nlm.nih.gov/9708225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9708225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent cyclic therapy with etidronate prevents corticosteroid-induced bone loss: two years of follow-up

1 reference

https://pubmed.ncbi.nlm.nih.gov/9708225

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/THX.53.5.351

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

8 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35532455&oldid=1578368684"